Project Intellectual Property. The Recipient must exclusively own and retain ownership of the Project Intellectual Property in Canada for the Term, unless otherwise agreed to by Canada’s Minister of Industry. The Recipient shall take appropriate steps to protect the Project Intellectual Property. For clarity, the Recipient shall manage the preparation, filing, prosecution, maintenance and enforcement of Program Intellectual Property in a commercially reasonable manner consistent with its overall portfolio of antibody programs, but this clarification does not relieve the Recipient of any other obligations herein.
Appears in 2 contracts
Samples: Contribution Agreement (AbCellera Biologics Inc.), Contribution Agreement (AbCellera Biologics Inc.)
Project Intellectual Property. The Recipient must exclusively own and retain ownership of the Project Intellectual Property in Canada for the Term, unless otherwise agreed to by Canada’s Minister of Industrythe Minister. The Recipient shall take appropriate steps to protect the Project Intellectual Property. For clarity, the Recipient shall manage the preparation, filing, prosecution, maintenance and enforcement of Program Intellectual Property in a commercially reasonable manner consistent with its overall portfolio of antibody programs, but this clarification does not relieve the Recipient of any other obligations herein.
Appears in 2 contracts
Samples: Strategic Innovation Fund Agreement (Edesa Biotech, Inc.), Sif Agreement (Algoma Steel Group Inc.)
Project Intellectual Property. The Recipient must exclusively own and retain ownership of the Project Intellectual Property in Canada for the TermTerm of this Agreement, unless otherwise agreed to by Canada’s the Minister of Industrywith the process outlined in Schedule 7. The Recipient shall take appropriate steps to protect the Project Intellectual Property. For clarity, the Recipient shall manage the preparation, filing, prosecution, maintenance and enforcement of Program Intellectual Property in a commercially reasonable manner consistent with its overall portfolio of antibody programs, but this clarification does not relieve the Recipient of any other obligations herein.
Appears in 1 contract
Samples: Strategic Innovation Fund Agreement (AbCellera Biologics Inc.)